These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 16126398)
1. Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer. Nakagawa T; Okumura N; Miyoshi K; Matsuoka T; Kameyama K Eur J Cardiothorac Surg; 2005 Oct; 28(4):635-9. PubMed ID: 16126398 [TBL] [Abstract][Full Text] [Related]
2. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment. Lee JG; Lee CY; Kim DJ; Chung KY; Park IK Eur J Cardiothorac Surg; 2008 Mar; 33(3):480-4. PubMed ID: 18249000 [TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of primary lung cancer with synchronous brain metastases. Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383 [TBL] [Abstract][Full Text] [Related]
5. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948 [TBL] [Abstract][Full Text] [Related]
6. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime]. Pfannschmidt J; Muley T; Hoffmann H; Dienemann H Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Casali C; Stefani A; Natali P; Rossi G; Morandi U Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease. Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188 [TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424 [TBL] [Abstract][Full Text] [Related]
11. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
12. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813 [TBL] [Abstract][Full Text] [Related]
13. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761 [TBL] [Abstract][Full Text] [Related]
14. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. Watanabe S; Asamura H; Suzuki K; Tsuchiya R Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954 [TBL] [Abstract][Full Text] [Related]
15. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M; Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041 [TBL] [Abstract][Full Text] [Related]
17. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis. Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794 [TBL] [Abstract][Full Text] [Related]
18. Postrecurrence survival in patients with stage I non-small cell lung cancer. Nakagawa T; Okumura N; Ohata K; Igai H; Matsuoka T; Kameyama K Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. Iwasaki A; Shirakusa T; Yoshinaga Y; Enatsu S; Yamamoto M Eur J Cardiothorac Surg; 2004 Sep; 26(3):488-93. PubMed ID: 15302040 [TBL] [Abstract][Full Text] [Related]